StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies r&d expenses

Research and development expenses are spending on new products and technology.

Neuroone Medical Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.40M, up 8.5% year over year. For fiscal 2025 it was $4.98M, down 1.6% from the year before. The highest annual figure on record is $6.94M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Sep 30, 2025$4.98M-1.6%
FY2024Sep 30, 2024$5.07M-27.0%
FY2023Sep 30, 2023$6.94M+40.8%
FY2022Sep 30, 2022$4.93M+25.6%
FY2021Sep 30, 2021$3.93M+89.1%
FY2020Sep 30, 2020$2.08M+182.3%
FY2017Dec 31, 2017$735.33K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$1.43M+20.5%
Q2 FY2026CQ1 2026Mar 31, 2026$1.47M-2.8%
Q1 FY2026CQ4 2025Dec 31, 2025$1.39M+18.6%
Q4 FY2025CQ3 2025Sep 30, 2025$1.12M+0.4%
Q3 FY2025CQ2 2025Jun 30, 2025$1.18M-1.0%
Q2 FY2025CQ1 2025Mar 31, 2025$1.51M+18.6%
Q1 FY2025CQ4 2024Dec 31, 2024$1.17M-21.0%
Q4 FY2024CQ3 2024Sep 30, 2024$1.11M-37.4%
Q3 FY2024CQ2 2024Jun 30, 2024$1.19M-36.8%
Q2 FY2024CQ1 2024Mar 31, 2024$1.27M-25.4%
Q1 FY2024CQ4 2023Dec 31, 2023$1.48M-5.1%
Q4 FY2023CQ3 2023Sep 30, 2023$1.78M+23.7%
Q3 FY2023CQ2 2023Jun 30, 2023$1.89M+54.4%
Q2 FY2023CQ1 2023Mar 31, 2023$1.71M+41.6%
Q1 FY2023CQ4 2022Dec 31, 2022$1.56M+47.4%
Q4 FY2022CQ3 2022Sep 30, 2022$1.44M+42.6%
Q3 FY2022CQ2 2022Jun 30, 2022$1.23M+36.0%
Q2 FY2022CQ1 2022Mar 31, 2022$1.21M+11.5%
Q1 FY2022CQ4 2021Dec 31, 2021$1.06M+13.5%
Q4 FY2021CQ3 2021Sep 30, 2021$1.01M+28.5%
Q3 FY2021CQ2 2021Jun 30, 2021$901.13K+101.5%
Q2 FY2021CQ1 2021Mar 31, 2021$1.08M+216.1%
Q1 FY2021CQ4 2020Dec 31, 2020$934.16K+86.2%
Q4 FY2020CQ3 2020Sep 30, 2020$784.72K+234.0%
Q3 FY2020CQ2 2020Jun 30, 2020$447.15K+64.6%
Q2 FY2020CQ1 2020Mar 31, 2020$342.10K+118.3%
Q1 FY2020CQ4 2019Dec 31, 2019$501.82K+596.6%
Q4 FY2017CQ4 2017Dec 31, 2017$234.93K–
Q3 FY2017CQ3 2017Sep 30, 2017$271.65K–
Q2 FY2017CQ2 2017Jun 30, 2017$156.72K–
Q1 FY2017CQ1 2017Mar 31, 2017$72.04K–

More Neuroone Medical Technologies figures

See a number that looks wrong?